FDA Approves New Influenza Vaccine Production Facility
The U.S. Food and Drug Administration (FDA) today announced that it has approved a new manufacturing facility used to produce influenza virus vaccines. The facility is approved for seasonal influenza vaccine production and could be used for the production of vaccine against the new 2009 H1N1 influenza strain.
As part of its overall pandemic influenza [...]
Multi-Faceted H1N1 Influenza Diagnostic Systems
Evogen, Inc., a molecular diagnostics company, is developing multi-faceted capabilities to address the air-monitoring, detection and diagnosis of Influenza A H1N1, or Swine Flu, in addition to several prevalent flu types.
Evogen’s molecular PCR diagnostic test is capable of rapidly and specifically detecting H1N1 pandemic Influenza, utilizing HyBeacons® technology. The test can be implemented on PCR [...]
